CN107951764A - 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 - Google Patents
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 Download PDFInfo
- Publication number
- CN107951764A CN107951764A CN201711120602.0A CN201711120602A CN107951764A CN 107951764 A CN107951764 A CN 107951764A CN 201711120602 A CN201711120602 A CN 201711120602A CN 107951764 A CN107951764 A CN 107951764A
- Authority
- CN
- China
- Prior art keywords
- extract
- mouth
- canker sore
- mucous membrane
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000020670 canker sore Diseases 0.000 title claims abstract description 65
- 230000000694 effects Effects 0.000 title claims abstract description 56
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 52
- 239000000606 toothpaste Substances 0.000 title claims abstract description 52
- 210000004400 mucous membrane Anatomy 0.000 title claims abstract description 43
- 230000008439 repair process Effects 0.000 title claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 101
- 241001103621 Psychotria Species 0.000 claims abstract description 28
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims abstract description 25
- 241001146155 Emilia Species 0.000 claims abstract description 25
- 235000019049 Emilia coccinea Nutrition 0.000 claims abstract description 25
- 241000488874 Sonchus Species 0.000 claims abstract description 23
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 claims abstract description 23
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000011701 zinc Substances 0.000 claims abstract description 23
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 23
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 22
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229940116229 borneol Drugs 0.000 claims abstract description 22
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 22
- 241000972672 Phellodendron Species 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 230000002265 prevention Effects 0.000 claims abstract description 14
- 239000011159 matrix material Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 239000003814 drug Substances 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 30
- 238000000605 extraction Methods 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000686 essence Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 244000033373 Pithecellobium clypearia Species 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000005292 vacuum distillation Methods 0.000 claims description 9
- 239000004909 Moisturizer Substances 0.000 claims description 7
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- 230000001333 moisturizer Effects 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 6
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000008216 herbs Nutrition 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 6
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 6
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 6
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 6
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 5
- -1 abrasive Substances 0.000 claims description 5
- 229940085605 saccharin sodium Drugs 0.000 claims description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 4
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 4
- 229960004998 acesulfame potassium Drugs 0.000 claims description 4
- 239000000619 acesulfame-K Substances 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 210000000003 hoof Anatomy 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 4
- 239000011746 zinc citrate Substances 0.000 claims description 4
- 235000006076 zinc citrate Nutrition 0.000 claims description 4
- 229940068475 zinc citrate Drugs 0.000 claims description 4
- 239000011576 zinc lactate Substances 0.000 claims description 4
- 235000000193 zinc lactate Nutrition 0.000 claims description 4
- 229940050168 zinc lactate Drugs 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 241000206575 Chondrus crispus Species 0.000 claims description 3
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 claims description 3
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 3
- 241001093501 Rutaceae Species 0.000 claims description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 3
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 3
- 235000008384 feverfew Nutrition 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 235000021374 legumes Nutrition 0.000 claims description 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 241001529246 Platymiscium Species 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 241001107098 Rubiaceae Species 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- 239000000551 dentifrice Substances 0.000 claims 4
- 238000003682 fluorination reaction Methods 0.000 claims 1
- 229960001031 glucose Drugs 0.000 claims 1
- 235000001727 glucose Nutrition 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 238000005469 granulation Methods 0.000 abstract description 5
- 230000003179 granulation Effects 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 230000001771 impaired effect Effects 0.000 abstract description 4
- 230000017074 necrotic cell death Effects 0.000 abstract description 4
- 230000000740 bleeding effect Effects 0.000 abstract description 2
- 210000000214 mouth Anatomy 0.000 description 42
- 238000003756 stirring Methods 0.000 description 12
- 208000025865 Ulcer Diseases 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 231100000397 ulcer Toxicity 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 8
- 208000002399 aphthous stomatitis Diseases 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000001151 other effect Effects 0.000 description 5
- 208000007117 Oral Ulcer Diseases 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000011344 liquid material Substances 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 244000299492 Thespesia populnea Species 0.000 description 3
- 235000009430 Thespesia populnea Nutrition 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical group C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 206010048259 Zinc deficiency Diseases 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000005548 health behavior Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- NWSWVIKHALGAER-UHFFFAOYSA-N 6beta-hydroxyamarilin Natural products C12C(C)CC3OC(=O)C(=C)C3C(O)C2(C)C(O)C2C1O2 NWSWVIKHALGAER-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000293268 Astragalus chinensis Species 0.000 description 1
- NWSWVIKHALGAER-KVLFNOHQSA-N Autumnolide Chemical group C[C@@H]([C@H]12)C[C@H]3OC(=O)C(=C)[C@H]3[C@H](O)[C@]2(C)[C@@H](O)[C@H]2[C@@H]1O2 NWSWVIKHALGAER-KVLFNOHQSA-N 0.000 description 1
- NWSWVIKHALGAER-VYEBAEBDSA-N Autumnolide Natural products O=C1C(=C)[C@H]2[C@H](O)[C@]3(C)[C@@H](O)[C@H]4O[C@H]4[C@H]3[C@H](C)C[C@@H]2O1 NWSWVIKHALGAER-VYEBAEBDSA-N 0.000 description 1
- 108091005950 Azurite Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241001063191 Elops affinis Species 0.000 description 1
- 235000002756 Erythrina berteroana Nutrition 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000868953 Hymenocardia acida Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010058667 Oral toxicity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000899 acute systemic toxicity Toxicity 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical group 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 231100000418 oral toxicity Toxicity 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940095688 toothpaste product Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- GWBUNZLLLLDXMD-UHFFFAOYSA-H tricopper;dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[O-]C([O-])=O.[O-]C([O-])=O GWBUNZLLLLDXMD-UHFFFAOYSA-H 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏。按重量百分比计,该中药牙膏是由以下原料组成:0.1~5%的黄柏提取物,0.1~5%的山大颜提取物,0.1~5%的猴耳环提取物,0.1~5%的羊蹄草提取物,0.05~0.3%的龙脑,0.1~0.7%的有机锌,其余为牙膏基质。该中药牙膏具有清热解毒、消肿止痛、化腐生肌、收敛止血的作用,能修复受损的口腔黏膜和预防口腔溃疡。
Description
技术领域
本发明涉及一种牙膏,属于口腔清洁护理产品技术领域,特别是涉及一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏。
背景技术
口腔溃疡又称“口疮”,是口腔疾病中发病率较高的一种疾病。口腔黏膜局部创伤、精神紧张、食物、药物、营养不良、激素水平改变及缺乏维生素(如叶酸、维生素B12等)或微量元素(如锌、铁等)均可偶发该病。其特点是口腔黏膜局限性溃疡损伤,以口腔的唇、颊、软腭或齿龈等处的黏膜多见,具有周期性、复发性、自限性的特点。发病年龄一般在10~30岁之间,女性较多,一年四季均可发生,口腔溃疡具有自限性,一般10天左右可以自愈。
口腔溃疡在很大程度上与个人身体素质和生活习惯有关,随着生活节奏加快,工作压力加大,造成人体免疫力下降,容易引发口腔溃疡。为了降低口腔溃疡,应养成良好的生活习惯,注意口腔卫生,避免损伤口腔黏膜,避免辛辣食物和局部刺激,保持心情舒畅,保证充足睡眠,避免过度疲劳,注意生活规律性和营养均衡性,尽量避免诱发口腔溃疡的不良因素。
口腔清洁护理产品对于降低口腔溃疡的发生具有重要作用,平时应选用刷毛柔软、刷面圆滑的保健型牙刷,配合具有预防口腔溃疡的保健型中草药牙膏使用,既能有效清洁口腔又能维护和修复口腔黏膜,这是对减少口腔溃疡的有效护理措施。
临床上西药治疗口腔溃疡,多以消炎为主,虽然疗效好,治疗时间短,但抗生素类消炎药对人体健康毒副作用较大,极易引起人体免疫力下降,还会破坏口腔微生态平衡,造成口腔溃疡的复发。而中药治疗口腔溃疡重在修复口腔微生态环境,虽然治疗时间长,但安全性高,毒副作用小,不易产生耐受性等特点,因此深受广大患者的青睐。
牙膏作为人们日常口腔清洁护理产品,已成为一种维护口腔健康的生活必需品。具有口腔溃疡的消费者,往往会选用具有针对性疗效的功效型牙膏。目前市场上具有预防口腔溃疡和修复口腔黏膜的中药牙膏并不多见,特别是同时含有黄柏、山大颜、猴耳环、羊蹄草的中药组合物,具有预防口腔溃疡和修复口腔黏膜的牙膏还未出现。因此开发一种功效显著的预防口腔溃疡和修复口腔黏膜的中药牙膏迫在眉睫。
发明内容
本发明的目的是提供一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,根据黄柏、山大颜、猴耳环、羊蹄草四味中药的药效原理,再复配功效促进剂,协同达到清热解毒、消肿止痛、化腐生肌、收敛止血,具有修复受损的口腔黏膜和预防口腔溃疡。
本发明通过以下技术方案来实现的:
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含0.4~20%的中药活性成分,0.15~1.0%的功效促进剂,79~99.45%基质成分。所述活性成分包含黄柏提取物、山大颜提取物,猴耳环提取物,羊蹄草提取物;所述功效促进剂包含龙脑和有机锌;所述基质成分包含保湿剂,磨擦剂,增稠剂,表面活性剂,甜味剂,防腐剂,香精及去离子水。
本发明的中药牙膏,按重量百分比计,所述中药活性成分包含的原料组分:0.1~5%的黄柏提取物,0.1~5%的山大颜提取物,0.1~5%的猴耳环提取物,0.1~5%的羊蹄草提取物。
进一步而言,所述功效促进剂成分包含的原料组分:0.05~0.3%的龙脑,0.1~0.7%的有机锌。
进一步而言,所述基质成分包含的原料组分:20~60%的保湿剂,15~45%的磨擦剂,0.8~1.5%的增稠剂,1.8~3%的表面活性剂,0.1~0.3%的甜味剂,0.1~0.3%的防腐剂,0.8~2%的香精,去离子水添加至100%。
进一步而言,所述黄柏提取物是指从芸香科植物黄柏的干燥树皮中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%。
进一步而言,所述山大颜提取物是从茜草科九节属植物山大颜的根、叶中提取的活性成分,包括提取液或提取物粉末,优选添加量为0.5%~2%。
进一步而言,所述猴耳环提取物是从豆科植物猴耳环的带叶茎枝中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%。
进一步而言,所述羊蹄草提取物是从菊科植物羊蹄草中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%。
进一步而言,所述黄柏提取物提取工艺为:
将黄柏粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得黄柏提取物;
所述山大颜提取物提取工艺为:将山大颜粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得山大颜提取物;
所述猴耳环提取物提取工艺为:将猴耳环粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得猴耳环提取物;
所述羊蹄草提取物提取工艺为:将羊蹄草粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得黄柏提取物。
进一步而言,所述功效促进剂为龙脑和有机锌两种混合物,其中有机锌包括柠檬酸锌、乳酸锌、葡糖糖酸锌中的任意一种,龙脑优选添加量0.1%~0.2%,有机锌优选添加量0.3%~0.5%。
进一步而言,所述保湿剂为山梨醇、甘油、聚乙二醇、丙二醇中的一种或多种混合物。
所述磨擦剂为碳酸钙、磷酸氢钙、二氧化硅、氢氧化铝中的一种或两种混合物。
所述增稠剂为羧甲基纤维素钠、黄原胶、瓜尔胶、卡拉胶中的一种或多种混合物。
所述表面活性剂为月桂醇硫酸钠、月桂酰肌氨酸钠、椰油酰基甜菜碱中的一种或多种混合物。
所述甜味剂为糖精钠、安赛蜜中的一种或两种混合物。
所述防腐剂为苯甲酸钠、尼泊金酯类中的一种或两种混合物。
上述牙膏还可以包含其它添加剂,如焦磷酸钠、氟化物、钛白粉等。
本发明具有预防口腔溃疡和修复口腔黏膜的中药功效牙膏具有以下优点和有益效果:
1、本发明依据中药传承理论,将黄柏、山大颜、猴耳环、羊蹄草四味中药提取物复配应用于牙膏中,既发挥了单味中药的活性,又使四味中药相辅相成,协同增效。具有清热解毒、凉血止血、消肿散瘀、化腐生肌的作用,共同促进口腔溃疡面的快速愈合,修复受损的口腔黏膜和预防口腔溃疡。
2、本发明添加了功效促进剂龙脑、有机锌,更好地协同中药组合物快速修复溃疡面,加速创口愈合。龙脑是治疗口腔溃疡广泛使用的药物,具有清热止痛、抑菌抗炎、防腐生机,对组织液体的渗出和组织水肿等炎症有抑制作用,龙脑还具有透皮吸收作用,能够促进中药的透皮吸收,提高中药的生物利用度;锌是人体必需的微量元素,缺锌会使人体免疫力下降,增加口腔溃疡的风险。锌具有收敛作用,能够促进黏膜再生,修复组织细胞,加速溃疡面的愈合。
本发明的牙膏同样含有具有清凉作用的薄荷脑,属于牙膏香精体系。薄荷脑具有芳香通窍,疏风散热,杀菌消毒作用,薄荷脑对神经末梢有抑制和麻痹作用,对溃疡面有镇痛和消炎作用,薄荷脑同样具有促进透皮吸收作用,能够改变皮肤表皮脂质结构,增加药物的透皮吸收能力。龙脑、锌盐、薄荷脑协同中药组合物互为补充和增效,形成一个完整的修复口腔黏膜的疗效体系。
3、本发明除具有修复口腔黏膜的临床疗效外,还具有预防口腔溃疡的保健作用,具有攻防兼备的双重效果。中医认为口腔溃疡是心火炽盛、胃火上攻,虚火上炎熏蒸于口而发病。本发明中药组合物中的黄柏、山大颜、猴耳环、羊蹄草均具有清热解毒、清热凉血作用,可以预防口腔上火,降低口腔溃疡发生的风险。锌盐可以补充人体必需的锌元素,预防缺锌导致的口腔溃疡。龙脑和香精中的薄荷脑有抗菌抑菌,清新口气,减少菌斑,预防和减轻牙龈炎,维护口腔清洁健康,预防口腔感染,降低口腔溃疡的发生。
4、本发明以牙膏为药物载体,在修复口腔黏膜方面,比单纯的中药制剂具有一定的优越性,即清洁口腔功能。口腔中的有害细菌如血链球菌和幽门螺杆菌也与口腔溃疡有密切关系。刷牙可以清洁整个口腔,减少细菌水平,单纯中药制剂不具有清洁口腔功能。
本发明具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,所含中药组份和功效促进剂能够大大降低口腔中的有害细菌,更好地预防口腔溃疡的发生和促进口腔溃疡面的愈合,相比中药制剂具有很好的使用性。在活性物生物利用度方面,消费者在清洁口腔时,活性成分通过口腔粘膜和舌下静脉直接吸收进入血液循环系统,避免肝脏的首过效应以及胃肠道酶和酸的降解作用对活性物的破坏,提高了活性物的吸收利用度,同样可以达到单纯中药制剂的效果。
5、本发明增加了人们预防口腔溃疡和修复口腔黏膜的途径,不再局限于药品,在日常口腔清洁护理的同时就能维护口腔健康,同时拓展了传统中药的应用领域,具有很强的实用性。
具体实施方式
本发明具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含0.4~20%的中药活性成分,0.15~1.0%的功效促进剂,79~99.45%的基质成分。所述基质成分包含保湿剂,磨擦剂,增稠剂,表面活性剂,甜味剂,防腐剂,香精及去离子水。
所述中药活性成分包含的原料组分:0.1~5%的黄柏提取物,0.1~5%的山大颜提取物,0.1~5%的猴耳环提取物,0.1~5%的羊蹄草提取物。
所述功效促进剂成分包含的原料组分:0.05~0.3%的龙脑,0.1~0.7%的有机锌。
所述预防口腔溃疡和修复口腔黏膜的功效成分相辅相成,协同增效。一方面具有清热解毒、消肿止痛、化腐生肌,促进溃疡面的愈合,另一方面具有清热解毒,可以预防口腔溃疡的发生。
本发明活性组分的作用机理简单表述如下:
黄柏,为芸香科植物黄柏的树皮,又称黄檗、元柏、檗木、檗皮。味苦,性寒,具有清热燥湿、泻火解毒、消肿止痛等功效。用于骨蒸痨热,目赤肿痛,口舌生疮,疮疡肿毒等。现代药理表明,黄柏提取物的主要活性成分是小檗碱,具有抗菌作用。
山大颜,为茜草科植物九节木的根、叶,又称九节木、大罗伞、火筒树、山大刀、暗山公、刀枪木。味苦,性凉,具有清热解毒、祛风除湿、消肿拔毒、防腐生肌等功效,属拔毒生肌药。用于扁桃体炎、咽喉炎、风湿骨痛,外用治跌打肿痛、外伤出血等。现代药理表明,山大颜提取物主要活性成分是堆心菊内酯、鞣质及甾类。
猴耳环,为豆科植物猴耳环带叶茎枝,又名围诞树、鸡心树、三不正、洗头树、落地金钱等。味苦、涩,性微寒,具有清热解毒、凉血消肿、去湿敛疮、祛腐生新等功效,用于上呼吸道感染、急性咽炎、急性扁桃体炎等。现代药理表明,猴耳环主要活性成分为黄酮苷、酚类。
羊蹄草,为菊科植物一点红的全草,又名一点红、叶下红、红背叶、红叶草、红花草、石青红。味苦,性凉,具有清热解毒、凉血止血、散瘀消肿等功效,用于上呼吸道感染,口腔溃疡等。现代药理表明,羊蹄草主要含有槲皮素、槲皮甙、芸香甙和黄酮类,具有抑菌作用。
龙脑,为菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸气蒸馏并结晶而得天然龙脑,也有化工合成的,味苦,性凉。具有清热解毒、消肿生肌、活血止痛、收敛疮面等功效,用于目赤肿痛、咽喉肿痛、牙痛、口舌生疮、溃后不敛,是治疗口腔溃疡的良药。
有机锌(包括柠檬酸锌、乳酸锌、葡萄糖酸锌),有机锌有利于人体吸收,且刺激性小。锌是人体必需的14种微量元素中较重要的一种,参与人体多种酶的合成,对生长发育、修复组织细胞、增强免疫力及提高小儿智力发育等具有重要作用,同时具有收敛作用,可以促进黏膜再生和加速溃疡面的愈合。
本发明公开的特征中药组合物:黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物以及功效促进剂龙脑和有机锌,含有以上特征的组合物牙膏,对修复口腔黏膜和预防口腔溃疡具有很好的适用性和临床效果,所述特征组合物未见应用于牙膏中成功案例,在牙膏产品领域属于首次应用,具有一定的新颖性和创造性。
下面通过具体较佳实施例进一步阐述本发明,但这些较佳实施例仅仅用于更详细说明之用,而不应用于以任何形式限制本发明,本领域技术人员应理解,本发明除以下实施例外,还可以做出其他类似的改变获得相似的结果而不脱离本发明的内容和精神范围。
以下特征中药组合物:黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物提取工艺为:将黄柏粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得黄柏提取物。另外,山大颜提取物、猴耳环提取物、羊蹄草提取物提取工艺同上。
实施例1
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含以下原料组分:
制作工艺如下:
1)将尼泊金酯、龙脑、香精称量后加入容器A中搅拌溶解;
2)将去离子水加入预混锅B中,然后加入糖精钠、安赛蜜、焦磷酸钠、月桂酰肌氨酸钠、柠檬酸锌、黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物,并搅拌溶解均匀;
3)将聚乙二醇-400、山梨醇加入预混锅C中;
4)将碳酸钙、二氧化硅、羧甲基纤维素钠、瓜耳胶、月桂醇硫酸钠加入混粉器中;
5)将预混锅B和预混锅C中的液料在真空状态下吸入制膏机,然后开动刮板和搅拌,吸入混粉器中的粉料,粉料进完后打开均质,均质脱气30分钟;
6)真空脱气30分钟后,吸入容器A中的原料,再均质脱气10分钟,检验合格后方可出膏。
实施例2
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含以下原料组分:
制作工艺如下:
1)将龙脑、香精称量后加入容器A中搅拌溶解;
2)将去离子水加入预混锅B中,然后加入苯甲酸钠、糖精钠、焦磷酸钠、椰油酰胺丙基甜菜碱、乳酸锌、黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物,并搅拌溶解均匀;
3)将丙二醇、甘油、山梨醇加入预混锅C中;
4)将磷酸氢钙、二氧化硅、羧甲基纤维素钠、黄原胶、月桂醇硫酸钠加入混粉器中;
5)将预混锅B和预混锅C中的液料在真空状态下吸入制膏机,然后开动刮板和搅拌,吸入混粉器中的粉料,粉料进完后打开均质,均质脱气30分钟;
6)真空脱气30分钟后,吸入容器A中的原料,再均质脱气10分钟,检验合格后方可出膏。
实施例3
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含以下原料组分:
制作工艺如下:
1)将尼泊金酯、龙脑、香精称量后加入容器A中搅拌溶解;
2)将去离子水加入预混锅B中,然后加入氟化钠、安赛蜜、焦磷酸钠、葡萄糖酸锌、黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物,并搅拌溶解均匀;
3)将聚乙二醇-600、山梨醇加入预混锅C中;
4)将二氧化硅、羧甲基纤维素钠、卡拉胶、月桂醇硫酸钠、钛白粉加入混粉器中;
5)将预混锅B和预混锅C中的液料在真空状态下吸入制膏机,然后开动刮板和搅拌,吸入混粉器中的粉料,粉料进完后打开均质,均质脱气30分钟;
6)真空脱气30分钟后,吸入容器A中的原料,再均质脱气10分钟,检验合格后方可出膏。
实施例4
一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,按重量百分比计,包含以下原料组分:
制作工艺如下:
1)将尼泊金酯、龙脑、香精称量后加入容器A中搅拌溶解;
2)将去离子水加入预混锅B中,然后加入糖精钠、焦磷酸钠、柠檬酸锌、黄柏提取物、山大颜提取物、猴耳环提取物、羊蹄草提取物,并搅拌溶解均匀;
3)将聚乙二醇-600、山梨醇加入预混锅C中;
4)将氢氧化铝、二氧化硅、羧甲基纤维素钠、瓜尔胶、月桂醇硫酸钠加入混粉器中;
5)将预混锅B和预混锅C中的液料在真空状态下吸入制膏机,然后开动刮板和搅拌,吸入混粉器中的粉料,粉料进完后打开均质,均质脱气30分钟;
6)真空脱气30分钟后,吸入容器A中的原料,再均质脱气10分钟,检验合格后方可出膏。
以下为效果试验例部分的内容。
1、急性全身毒性试验(经口途径)部分
健康ICR小鼠50只,雌雄各半,体重18~20g,随机分成5组(1组为对照组,4组为不同剂量组),每组10只。将本发明实施例2的中药牙膏加蒸馏水配成30%悬浮液,按小鼠最大允许容量给服,设置,所给剂量折算成原牙膏量依次为18、14、10、6(g.kg-1)。在动物禁食(不禁水)18小时后,1日内分两次给服(间隔半小时),但合并作为一次剂量计算,对照组给服同等剂量的蒸馏水。灌胃给服后4h、24h、48h、72h,观察动物一般状态、毒性表现和死亡动物数。
结果:72h观察期内,当用最大允许浓度和最大允许容量(18g/kg.d)给予小鼠时,未观察到小鼠死亡。小鼠食欲、活动、毛色、精神状态等均和对照组无明显差异,即无急性全身毒性反应,根据经口毒性分级,LD50(mg/kg)>5000为实际无毒物质,本试验最大剂量为18g/kg.d,远远大于5000mg/kg.d,故本发明实施例2的中药牙膏具有安全性。
2、对醋酸致豚鼠口腔溃疡模型试验部分
健康豚鼠40只,雌雄各半,体重300~350g,在实验室适应3天,分别从豚鼠面颊部左侧进针至面颊黏膜下,注射10%醋酸0.05ml/只,造成口腔溃疡模型。于注射后的第2、3天观察并测量其口腔溃疡面积。
将形成溃疡的40只豚鼠随机分成4组,每组10只,第1组为空白对照组,第2组为高剂量组,第3组为中剂量组,第4组为低剂量组。并在第3天测量溃疡面积后按规定剂量涂抹本发明中药牙膏,高剂量组每天涂抹5次,中剂量组每天涂抹3次,低剂量组每天涂抹2次。连续涂抹4天,每天测量并记录溃疡面积的变化,结果见表1。
表1 本发明的中药牙膏对豚鼠口腔溃疡的影响(X±S)A/mm2
组别 | 涂前 | 1d | 2d | 3d | 4d |
空白对照组 | 32.02±11.01 | 32.67±10.19 | 29.36±8.28 | 26.36±7.26 | 20.67±9.32 |
高剂量组 | 32.54±11.02 | 18.47±6.94*** | 16.51±7.24*** | 13.01±7.57*** | 9.36±7.81*** |
中剂量组 | 31.77±12.50 | 24.90±9.53* | 18.29±8.26** | 14.26±7.34** | 9.40±5.01*** |
低剂量组 | 33.01±10.07 | 25.01±6.48 | 17.61±7.80* | 13.01±7.23* | 12.29±8.24** |
与空白对照比较*P<0.05,**P<0.01,***P<0.001。
由表1结果表明,本发明的中药牙膏高剂量组、中剂量组、低剂量组与空白对照组比较具有显著差异,说明本发明可明显缩小醋酸所致豚鼠口腔溃疡面积,促进溃疡面的愈合,修复受损的口腔黏膜。
3、临床试验部分
本次临床试验选取70例不同程度的口腔溃疡患者,其中男性32人,女性38人,年龄在18~45岁,随机分成试验组和对照组,每组35人。试验组每天用本发明实施例2的中药牙膏刷牙3次,早、中、晚各一次,每次不少于3分钟,对照组使用不含本发明活性成分的空白牙膏,使用方法同试验组,试验期间患者忌用其它治疗口腔溃疡的药物,忌辛辣食物。
评价标准:
痊愈:用本发明中药牙膏7天内口腔溃疡完全愈合,且6个月内未见复发。
显效:用本发明中药牙膏7天内口腔溃疡完全愈合,且3个月内未见复发。
好转:用本发明中药牙膏7天内口腔溃疡完全愈合,且1个月内未见复发。
无效:用本发明中药牙膏7天以上口腔溃疡未见愈合。
使用调查结果统计见表2。
表2调查结果统计
组别 | 人数 | 痊愈 | 显效 | 好转 | 无效 | 有效率% |
试验组 | 35 | 16 | 12 | 5 | 2 | 94% |
对照组 | 35 | 1 | 2 | 6 | 26 | 26% |
试验表明,本发明的中药牙膏对口腔溃疡总有效率达到94%,产生了意想不到的效果。整个试验期间,试验组受试者未出现不良反应现象,说明本发明的中药牙膏具有促进口腔溃疡愈合的临床效果和安全适用性,达到了预期目的。相对于单味中药而言,中药组合物具有叠加和协同增效效应,这正是本发明的中药组合思路,也是中药及其应用的博大精深之处。
以上所述的实施例只是对本发明的有限阐述,并非对本发明作任何形式上的限制,在不脱离本发明的精神和范围条件下,对实施例所作的修改,均属于本发明技术方案的范围内。
Claims (9)
1.一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:按牙膏组合物的总重量计,所述中药牙膏包含0.4~20%的中药活性成分,0.15~1.0%的功效促进剂,79.0~99.45%基质成分;所述活性成分包含黄柏提取物、山大颜提取物,猴耳环提取物,羊蹄草提取物;所述功效促进剂包含龙脑和有机锌;所述基质成分包含保湿剂,磨擦剂,增稠剂,表面活性剂,甜味剂,防腐剂,香精及去离子水。
2.根据权利要求1所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:按牙膏组合物的总重量计,所述中药活性成分包含的原料组分:0.1~5%的黄柏提取物,0.1~5%的山大颜提取物,0.1~5%的猴耳环提取物,0.1~5%的羊蹄草提取物。
3.根据权利要求1所述的具有预防口腔溃疡和修复口腔黏膜的中药牙膏,其特征在于:按牙膏组合物的总重量计,所述功效促进剂成分包含的原料组分:0.05~0.3%的龙脑,0.1~0.7%的有机锌。
4.根据权利要求1所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:按牙膏组合物的总重量计,所述基质成分包含的原料组分:20~60%的保湿剂,15~45%的磨擦剂,0.8~1.5%的增稠剂,1.8~3%的表面活性剂,0.1~0.3%的甜味剂,0.1~0.3%的防腐剂,0.8~2%的香精,去离子水添加至100%。
5.根据权利要求2所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:
所述黄柏提取物是指从芸香科植物黄柏的干燥树皮中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%;
所述山大颜提取物是从茜草科九节属植物山大颜的根、叶中提取的活性成分,包括提取液或提取物粉末,优选添加量为0.5%~2%;
所述猴耳环提取物是从豆科植物猴耳环的带叶茎枝中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%;
所述羊蹄草提取物是从菊科植物羊蹄草中提取的活性成分,包括提取液和提取物粉末,优选添加量为0.5%~2%。
6.根据权利要求5所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:所述黄柏提取物提取工艺为:
将黄柏粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得黄柏提取物;
所述山大颜提取物提取工艺为:将山大颜粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得山大颜提取物;
所述猴耳环提取物提取工艺为:将猴耳环粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得猴耳环提取物;
所述羊蹄草提取物提取工艺为:将羊蹄草粉碎成大约40目,加10倍量的乙醇加热回流提取3小时,提取3次,合并提取液,然后减压蒸馏回收乙醇,浓缩成中药浸膏,减压干燥,粉碎得黄柏提取物。
7.根据权利要求3所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:所述功效促进剂为龙脑和有机锌两种混合物,其中有机锌为柠檬酸锌、乳酸锌、葡糖糖酸锌中的任意一种,龙脑优选添加量0.1%~0.2%,有机锌优选添加量0.3%~0.5%。
8.根据权利要求4所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:
所述保湿剂为山梨醇、甘油、聚乙二醇、丙二醇中的一种或多种混合物;
所述磨擦剂为碳酸钙、磷酸氢钙、二氧化硅、氢氧化铝中的一种或两种混合物;
所述增稠剂为羧甲基纤维素钠、黄原胶、瓜尔胶、卡拉胶中的一种或多种混合物;
所述表面活性剂为月桂醇硫酸钠、月桂酰肌氨酸钠、椰油酰基甜菜碱中的一种或多种混合物;
所述甜味剂为糖精钠、安赛蜜中的一种或两种混合物;
所述防腐剂为苯甲酸钠、尼泊金酯类中的一种或两种混合物。
9.根据权利要求1~8中任一项所述的具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏,其特征在于:所述牙膏还可以包含其它添加剂,所述其它添加剂选自焦磷酸钠、氟化物、钛白粉中的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711120602.0A CN107951764A (zh) | 2017-11-14 | 2017-11-14 | 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711120602.0A CN107951764A (zh) | 2017-11-14 | 2017-11-14 | 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107951764A true CN107951764A (zh) | 2018-04-24 |
Family
ID=61964445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711120602.0A Pending CN107951764A (zh) | 2017-11-14 | 2017-11-14 | 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107951764A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888308A (zh) * | 2020-08-04 | 2020-11-06 | 北京华素制药股份有限公司 | 一种预防口腔溃疡和加速口腔粘膜修复的牙膏及工艺 |
CN112336678A (zh) * | 2020-12-03 | 2021-02-09 | 滁州向日葵药业有限公司 | 一种清新口气的牙膏 |
CN112891379A (zh) * | 2019-12-04 | 2021-06-04 | 郭荣奎 | 一种用于婴幼儿鹅口疮的药物组合物及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103221031A (zh) * | 2010-08-07 | 2013-07-24 | 美国纽约州立大学研究基金会 | 包含锌化合物和抗微生物剂的口服组合物 |
CN104587239A (zh) * | 2014-12-24 | 2015-05-06 | 张莘蔓 | 一种含一点红的中药组合物及其制备方法 |
CN105055205A (zh) * | 2015-07-24 | 2015-11-18 | 安徽建筑大学 | 一种药物牙膏及其制备方法 |
CN105534787A (zh) * | 2015-12-25 | 2016-05-04 | 名臣健康用品股份有限公司 | 草本植物苎麻根和羊蹄根提取物在口腔护理产品中的应用 |
CN106727268A (zh) * | 2017-02-22 | 2017-05-31 | 云南白药集团股份有限公司 | 口腔崩解片及其制备方法 |
CN106729005A (zh) * | 2016-11-18 | 2017-05-31 | 广西大学 | 一种治疗口腔溃疡的中药制剂 |
CN107496263A (zh) * | 2017-10-11 | 2017-12-22 | 付金龙 | 中药牙膏及其制备方法 |
-
2017
- 2017-11-14 CN CN201711120602.0A patent/CN107951764A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103221031A (zh) * | 2010-08-07 | 2013-07-24 | 美国纽约州立大学研究基金会 | 包含锌化合物和抗微生物剂的口服组合物 |
CN104587239A (zh) * | 2014-12-24 | 2015-05-06 | 张莘蔓 | 一种含一点红的中药组合物及其制备方法 |
CN105055205A (zh) * | 2015-07-24 | 2015-11-18 | 安徽建筑大学 | 一种药物牙膏及其制备方法 |
CN105534787A (zh) * | 2015-12-25 | 2016-05-04 | 名臣健康用品股份有限公司 | 草本植物苎麻根和羊蹄根提取物在口腔护理产品中的应用 |
CN106729005A (zh) * | 2016-11-18 | 2017-05-31 | 广西大学 | 一种治疗口腔溃疡的中药制剂 |
CN106727268A (zh) * | 2017-02-22 | 2017-05-31 | 云南白药集团股份有限公司 | 口腔崩解片及其制备方法 |
CN107496263A (zh) * | 2017-10-11 | 2017-12-22 | 付金龙 | 中药牙膏及其制备方法 |
Non-Patent Citations (2)
Title |
---|
刘修树等: "《天然药物化学》", 31 January 2017, 华中科技大学出版社 * |
张晓南等: "《工业品商品学》", 30 April 2006, 中国物资出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112891379A (zh) * | 2019-12-04 | 2021-06-04 | 郭荣奎 | 一种用于婴幼儿鹅口疮的药物组合物及其应用 |
CN111888308A (zh) * | 2020-08-04 | 2020-11-06 | 北京华素制药股份有限公司 | 一种预防口腔溃疡和加速口腔粘膜修复的牙膏及工艺 |
CN111888308B (zh) * | 2020-08-04 | 2022-05-03 | 北京华素制药股份有限公司 | 一种预防口腔溃疡和加速口腔粘膜修复的牙膏及工艺 |
CN112336678A (zh) * | 2020-12-03 | 2021-02-09 | 滁州向日葵药业有限公司 | 一种清新口气的牙膏 |
CN112336678B (zh) * | 2020-12-03 | 2023-06-20 | 滁州向日葵药业有限公司 | 一种清新口气的牙膏 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178844B (zh) | 一种治疗牙龈肿痛的口腔中药制剂及其制备方法 | |
CN104666621B (zh) | 一种具有止血、消炎和抑菌作用的中药组合物及含其牙膏 | |
US20100129296A1 (en) | Extract of trigonella foenum-graecum | |
KR101481371B1 (ko) | 울금을 함유한 치약 조성물 및 그 제조 방법 | |
US20120288454A1 (en) | Dental protection toothpaste composition | |
CN106580866A (zh) | 儿童用牙膏 | |
CN102119995B (zh) | 治疗牙龈肿痛的中药 | |
CN108379139B (zh) | 一种防治口腔溃疡的牙膏及其制备方法和应用 | |
CN107951764A (zh) | 一种具有预防口腔溃疡和修复口腔黏膜功效的中药牙膏 | |
CN106309286A (zh) | 一种漱口水及其制备方法 | |
CN107811913A (zh) | 一种中药组合物在口腔护理产品中的应用 | |
CN104383350B (zh) | 一种中药复方漱口泡腾片及其制备方法 | |
CN107970286B (zh) | 一种治疗肾虚型牙齿松浮脱落的中药喷雾及其制备方法 | |
CN106344459A (zh) | 一种丹参净油祛痘洗面奶及其制备方法 | |
CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN105168058A (zh) | 一种含中药炭的本体黑时尚牙膏 | |
CN107569580B (zh) | 一种治疗痔疮的外用中药组合物及其制备方法 | |
CN109953921A (zh) | 一种清热祛火牙膏及其制备方法 | |
KR20040063187A (ko) | 약초를 함유한 치약 조성물 | |
CN108309863A (zh) | 一种玉米芯中草药牙粉 | |
CN107648437A (zh) | 一种治疗鼻炎的中药膏 | |
CN102018887B (zh) | 一种洁牙药物组合提取物及其功能卷烟 | |
CN107812080A (zh) | 一种治疗口腔溃疡的泡腾片及其制备方法 | |
CN109646591B (zh) | 一种用于口腔的组合物及其应用 | |
CN106177269A (zh) | 速效治疗口腔黏膜疾病的药物组合物、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180424 |
|
RJ01 | Rejection of invention patent application after publication |